date:Mar 14, 2013
ntage in these days and had to accept a stronger decline in 2012 than over the previous years.
In CSMs Purac business, fiscal-year EBITA was 39.2 million, down from 41.9 million. Excluding one-off costs, EBITA was 40.3 million, down from 46.1 million. Puracs fiscal-year net sales rose to 416.8 million from 407.2 million. The Chemicals and Pharma segment had higher sales, but the Food Ingredients segment had lower sales.
Companywide, CSM in the fourth quarter had EBITA of 36.3 million, up from